Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gareth J Veal

Showing results (1-10 of 101) with videos related to

Pageof 11
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 14, 2025
Understanding the Potential Importance of Pharmacokinetic Variability in the Setting of ALLGareth J Veal
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 2, 2012
Carboplatin dosing in infants with retinoblastoma: a case for therapeutic drug monitoringGareth J Veal, Alan V Boddy
Seminars in Fetal & Neonatal Medicine|April 3, 2012
Chemotherapy in newborns and preterm babiesGareth J Veal, Alan V Boddy
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 5, 2010
Clinical pharmacology in the adolescent oncology patientGareth J Veal, Christine M Hartford, Clinton F Stewart
Investigational New Drugs|August 2, 2003
Chemotherapy individualizationGareth J Veal, Sally A Coulthard, Alan V Boddy
British Journal of Clinical Pharmacology|June 11, 2020
Over a decade of experience with carboplatin therapeutic drug monitoring in a childhood cancer setting in the United KingdomShelby Barnett, Jordon Kong, Guy Makin, et al.
European Journal of Clinical Investigation|April 1, 2019
A novel imaging flow cytometry method for the detection of histone H4 acetylation in myeloid cellsSuriyon Uitrakul, Claire Hutton, Gareth J Veal, et al.
British Journal of Haematology|January 6, 2016
Personalization of dexamethasone therapy in childhood acute lymphoblastic leukaemiaRosanna K Jackson, Julie A E Irving, Gareth J Veal
Pharmacogenomics|September 13, 2012
Institutional profile: pharmacogenomics research at Newcastle UniversityAnn K Daly, Gareth J Veal, David Jamieson, et al.
Frontiers in Oncology|January 24, 2022
Perspectives and Expertise in Establishing a Therapeutic Drug Monitoring Programme for Challenging Childhood Cancer Patient PopulationsShelby Barnett, Victoria Holden, Quentin Campbell-Hewson, et al.
Pageof 11

Showing results (1-10 of 101) with videos related to

Sort By:
Pageof 11
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 14, 2025
Understanding the Potential Importance of Pharmacokinetic Variability in the Setting of ALLGareth J Veal
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 2, 2012
Carboplatin dosing in infants with retinoblastoma: a case for therapeutic drug monitoringGareth J Veal, Alan V Boddy
Seminars in Fetal & Neonatal Medicine|April 3, 2012
Chemotherapy in newborns and preterm babiesGareth J Veal, Alan V Boddy
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 5, 2010
Clinical pharmacology in the adolescent oncology patientGareth J Veal, Christine M Hartford, Clinton F Stewart
Investigational New Drugs|August 2, 2003
Chemotherapy individualizationGareth J Veal, Sally A Coulthard, Alan V Boddy
British Journal of Clinical Pharmacology|June 11, 2020
Over a decade of experience with carboplatin therapeutic drug monitoring in a childhood cancer setting in the United KingdomShelby Barnett, Jordon Kong, Guy Makin, et al.
European Journal of Clinical Investigation|April 1, 2019
A novel imaging flow cytometry method for the detection of histone H4 acetylation in myeloid cellsSuriyon Uitrakul, Claire Hutton, Gareth J Veal, et al.
British Journal of Haematology|January 6, 2016
Personalization of dexamethasone therapy in childhood acute lymphoblastic leukaemiaRosanna K Jackson, Julie A E Irving, Gareth J Veal
Pharmacogenomics|September 13, 2012
Institutional profile: pharmacogenomics research at Newcastle UniversityAnn K Daly, Gareth J Veal, David Jamieson, et al.
Frontiers in Oncology|January 24, 2022
Perspectives and Expertise in Establishing a Therapeutic Drug Monitoring Programme for Challenging Childhood Cancer Patient PopulationsShelby Barnett, Victoria Holden, Quentin Campbell-Hewson, et al.
Pageof 11